arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Connect Biopharma Holdings Limited

CNTB Health Care Biotechnology: Pharmaceutical Preparations
$0.74
▼ -7.7% Today
as of Oct 23, 13:46 ET
Last 30 days -56.72% Sep 14 → Oct 23
$0.67 $0.95 $1.24 $1.52 $1.80 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$0.80
High
$0.82
Low
$0.73
Volume
$1M
Avg Vol
$1M
Mkt Cap
$62M
P/E (TTM)
—
Beta
—
52w High
$3.82
52w Low
$0.73
Div Yield
—
Shares Out
$63M

Recent Press Releases & News last 60 days · 10 items

Oct 22 · 12:35 Zacks
Down 25.4% in 4 Weeks, Here's Why Connect Biopharma Holdings (CNTB) Looks Ripe for a Turnaround
Oct 19 · 12:55 Zacks
Here's Why Connect Biopharma Holdings (CNTB) Could be Great Choice for a Bottom Fisher
Oct 4 · 07:02 MarketBeat
Connect Biopharma COPD Study Shows 81% Cut in Treatment Failures
▸ Show all 10 press releases & news Free account →

CNTB earnings at a glance

The options market is pricing a move of about ±33.2% after the report, a range of roughly $0.49 to $0.99 from today's $0.74. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±10.1% on average; after the most recent report on May 12, 2026 it moved +14.5%. That means options currently expect more movement than CNTB has typically delivered. CNTB beat the consensus EPS estimate in 1 of its last 4 reported quarters. Implied volatility is currently 281%. The share price of $0.74 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.73
$3.82
0% of range
Avg surprise (last 4)
-6.0%
Avg reaction (last 2)
+4.5%
50% positive
Latest IV / EM
281%
EM ±33.2% · $1 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.34$-0.19$-0.03$0.12$0.27 Actual $-0.16Actual $0.27Actual $-0.23Actual $-0.19Est $-0.26Actual $-0.23Est $-0.22Actual $-0.31Est $-0.24Actual $-0.34Est $-0.29Actual $-0.27 MarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-19M$-14M$-8M$-3M$3M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.27 — — — — financials
Tue May 12, 2026Mar/2026 $-0.34 $-0.29 -17.2% -79.0% +14.5% earnings
Wed Nov 12, 2025Sep/2025 $-0.31 $-0.24 -29.2% — — earnings
Wed Aug 13, 2025Jun/2025 $-0.23 $-0.22 -4.5% — — earnings
Thu May 15, 2025Mar/2025 $-0.19 $-0.26 +26.9% — -5.6% earnings
Mon Sep 30, 2024Sep 2024 $-0.23 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.27 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.16 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$3M$169,000—$16,000$48,000$0—$1M
Cost of revenue————————
Gross profit————————
Operating income$-18M$-20M—$-18M$-13M$-11M—$-14M
Net income$-17M$-19M—$-17M$-13M$-10M—$-13M
EPS (diluted)$-0.27$-0.34—$-0.31$-0.23$-0.19—$-0.23

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$27M$46M$38M$38M$41M$48M$78M—
Inventory————————
Total current assets$39M$55M$51M$63M$78M$88M$97M—
Total assets$43M$60M$56M$67M$83M$93M$101M—
Long-term debt————————
Total liabilities$17M$17M$14M$12M$11M$10M$9M—
Total equity$27M$43M$42M$55M$71M$83M$92M$101M

Implied volatility — last 90 days

121%1251%2381%3510%4640% Jun 07 — IV 200% · EM ±27.6%Jun 08 — IV 207% · EM ±27.3%Jun 09 — IV 226% · EM ±28.3%Jun 10 — IV 265% · EM ±31.2%Jun 11 — IV 302% · EM ±33.3%Jun 12 — IV 300% · EM ±30.7%Jun 15 — IV 503% · EM ±36.4%Jun 16 — IV 723% · EM ±42.7%Jun 17 — IV 1151% · EM ±48.1%Jul 01 — IV 144% · EM ±24.1%Jul 02 — IV 151% · EM ±24.4%Jul 07 — IV 205% · EM ±27.0%Jul 08 — IV 216% · EM ±27.0%Jul 10 — IV 126% · EM ±13.9%Jul 13 — IV 282% · EM ±23.6%Jul 14 — IV 205% · EM ±14.9%Jul 15 — IV 279% · EM ±16.5%Jul 16 — IV 461% · EM ±19.3%Jul 20 — IV 180% · EM ±42.6%Jul 21 — IV 185% · EM ±43.0%Jul 22 — IV 189% · EM ±43.2%Jul 23 — IV 192% · EM ±43.2%Jul 24 — IV 222% · EM ±49.1%Jul 27 — IV 239% · EM ±50.0%Jul 29 — IV 158% · EM ±31.7%Jul 30 — IV 134% · EM ±26.3%Aug 03 — IV 129% · EM ±22.8%Aug 04 — IV 126% · EM ±21.7%Aug 05 — IV 122% · EM ±20.4%Aug 07 — IV 189% · EM ±29.5%Aug 24 — IV 265% · EM ±55.4%Aug 25 — IV 200% · EM ±40.8%Aug 26 — IV 236% · EM ±47.2%Aug 27 — IV 190% · EM ±37.3%Aug 28 — IV 223% · EM ±42.6%Aug 31 — IV 326% · EM ±57.7%Sep 01 — IV 234% · EM ±40.3%Sep 02 — IV 369% · EM ±61.6%Sep 03 — IV 412% · EM ±66.6%Sep 04 — IV 329% · EM ±51.4%Sep 07 — IV 373% · EM ±51.6%Sep 08 — IV 515% · EM ±68.1%Sep 09 — IV 486% · EM ±60.9%Sep 10 — IV 580% · EM ±68.5%Sep 11 — IV 585% · EM ±64.6%Sep 14 — IV 816% · EM ±68.2%Sep 15 — IV 3397% · EM ±245.7%Sep 16 — IV 3277% · EM ±193.5%Sep 17 — IV 4640% · EM ±193.8%Sep 21 — IV 717% · EM ±149.6%Sep 22 — IV 881% · EM ±180.3%Sep 23 — IV 1305% · EM ±261.4%Sep 24 — IV 773% · EM ±151.4%Sep 25 — IV 888% · EM ±169.9%Sep 28 — IV 1077% · EM ±190.9%Sep 29 — IV 3103% · EM ±534.3%Sep 30 — IV 1564% · EM ±261.3%Oct 01 — IV 1560% · EM ±252.3%Oct 02 — IV 2692% · EM ±420.7%Oct 06 — IV 2091% · EM ±276.1%Oct 08 — IV 281% · EM ±33.2%

Sector peers

BOLD
Boundless Bio, Inc.
$60M $2.38-2.7%
CLNN
Clene Inc.
$57M $3.84+2.1%
HYPD
Hyperion DeFi, Inc.
$57M $2.83-8.6%
CING
Cingulate Inc.
$69M $4.75+1.9%
CTOR
Citius Oncology, Inc.
$71M $0.68-2.6%
PDSB
PDS Biotechnology Corporation
$51M $1.10-11.4%

CNTB earnings FAQ

What is CNTB's expected move for earnings?

Options currently price a move of about ±33.2%, or $0.25 per share either way from $0.74.

How does CNTB stock usually react to earnings?

Across the last 2 reports the average next-day move was ±10.1%, up 1 times and down 1 times.

What is CNTB's implied volatility?

CNTB's at-the-money implied volatility is about 281% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in